DIMERIX LTD ORDINARY (DXB) Short Interest
DIMERIX LTD ORDINARY (ASX:DXB) had 0.03% of shares reported as short positions as of 26 June 2026, representing 160,566 shares. DIMERIX LTD ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
DXB
Dimerix
Pharmaceuticals, Biotechnology & Life Sciences
Dimerix is a clinical-stage biopharmaceutical company leveraging its proprietary Receptor-HIT platform to develop patient-preferred pharmaceutical products for global markets. Their focus is on identifying and developing drugs for areas with unmet needs, particularly in inflammatory diseases affecting the kidney and lungs.
biopharmaceutical
clinical stage
receptor-HIT
kidney disease
Shorted
short percentage0.03%
reported shorts160.6K
shares on issue600.397M